Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile G. D. BartoszykC. van AmsterdamC. A. Seyfried OriginalPaper 31 December 2003 Pages: 113 - 126
Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain L. LinnérC. WikerT. H. Svensson OriginalPaper 12 December 2003 Pages: 127 - 139
Long-term retention of neurotoxic β-carbolines in brain neuromelanin A. Ö:stergrenA. AnnasE. B. Brittebo OriginalPaper 03 December 2003 Pages: 141 - 157
Altered cellular distribution of iron in rat cerebral cortex during the oestrous cycle G. M. BishopL. E. SwanS. R. Robinson OriginalPaper 31 December 2003 Pages: 159 - 165
Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis J. Iłżecka OriginalPaper 12 December 2003 Pages: 167 - 172
Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients F. StocchiL. BarbatoT. Caraceni OriginalPaper Pages: 173 - 180
No nerve growth factor response to treatment with memantine in adult rats U. E. LangM. MühlbacherR. Hellweg OriginalPaper 29 December 2003 Pages: 181 - 190
A novel screen for nuclear mitochondrial gene associations with Parkinson’s disease G. D. MellickP. A. SilburnA. J. Brookes OriginalPaper 12 December 2003 Pages: 191 - 199
Diagnostic staging of Parkinson’s disease: conceptual aspects H. PrzuntekTh. MüllerP. Riederer OriginalPaper Pages: 201 - 216
Association analysis of the −308G > A promoter polymorphism of the tumor necrosis factor alpha (TNF-α) gene in Japanese patients with schizophrenia R. HashimotoM. YoshidaH. Kunugi Short Communication Pages: 217 - 221
Topography of spectral EEG and late VEP components in patients with Benign Rolandic Epilepsy of Childhood W. SkrandiesD. Dralle OriginalPaper 29 December 2003 Pages: 223 - 230